Independent fund research. Built on SEC filings.

How we research funds

ETF · Mid-Cap · BNY Mellon / Dreyfus

BNY Mellon US Mid Cap Core Equity ETF (BKMC)

Ticker BKMC · Since 2020-04-07 · · Holdings as of Jul 31, 2026

Expense ratio
0.04%$4/yr per $10k
5-yr return
+8.6%annualized
1-yr return
+8.6%as of Dec 2025
Net assets
$647.8Mall share classes
Holdings
405

Bottom line

Is BKMC a good fund? The bottom line

BKMC is a managed mid-cap ETF from BNY Mellon / Dreyfus.

Annual fees run 0.04% — about $4 a year on every $10,000 invested, cheaper than 98% of mid-cap funds we track.

It returned +8.6% over one year, +8.6% a year over five years (as of Dec 31, 2025, per its prospectus).

With $648 million in net assets and 405 holdings, its largest position is Drey Inst Pref Gov Mm-m (1.0%) and the top 10 make up 6.8% of the portfolio.

What stands out

  • Low cost: cheaper than 98% of mid-cap peers
  • Broadly diversified (405 holdings)

Updated Nov 19, 2026

What BKMC invests in

The fund seeks to track the performance of the Solactive GBS United States 400 Index TR.

To pursue its goal, the fund normally invests substantially all of its assets in equity securities comprising the Solactive GBS United States 400 Index TR (index). Under normal circumstances, the fund will invest at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of medium-capitalization U.S. companies, ETFs providing exposure to such securities, and derivatives with economic characteristics similar to such securities. The fund considers medium-capitalization companies to be companies with market capitalizations within the range of market capitalization of companies included in the index. As of December 31, 2025, the full market capitalization range of companies included in the index was $429 million to $32.10 billion. The fund considers a U.S. company to be a company whose securities are listed on a U.S. stock market. The Solactive GBS…

From the fund's prospectus (filed Feb 27, 2026).

BKMC performance

Fund calendar-year total returns, 2021–2025 2021: +23.7%; 2022: −15.9%; 2023: +17.5%; 2024: +14.0%; 2025: +8.6% +23.7% 2021 −15.9% 2022 +17.5% 2023 +14.0% 2024 +8.6% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
BKMC+8.6%+8.6%—
Mid-Cap median+7.9%+8.1%+9.9%

Source: Fund prospectus, as of Dec 31, 2025

Full BKMC performance history →

What BKMC costs

On a $10,000 investment, BKMC's 0.04% expense ratio costs about $4 a year. The prospectus estimates $51 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.

See the full BKMC fee table →

BKMC top 10 holdings

#Holding% of fund
1Drey Inst Pref Gov Mm-m1.00%
2Revolution Medicines Inc RVMD0.87%
3Twilio Inc TWLO0.72%
4Carpenter Technology Corp CRS0.64%
5Nvent Electric Plc NVT0.63%
6Ati Inc ATI0.63%
7Okta Inc OKTA0.62%
8F5 Inc FFIV0.58%
9Burlington Stores Inc BURL0.57%
10US Foods Holding Corp USFD0.57%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 6.8% of the fund. See all top 25 holdings and asset mix →

Alternatives to BKMC

More funds like BKMC →

BKMC FAQ

What is the expense ratio of BKMC?
BKMC's expense ratio is 0.04%, which works out to about $4 a year for every $10,000 invested. The prospectus estimates total costs of $51 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is BKMC a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 98% of mid-cap peers; broadly diversified (405 holdings). This is general information, not personalized advice.
What does BKMC hold?
BKMC's largest holdings are Drey Inst Pref Gov Mm-m (1.0%), Revolution Medicines Inc (0.9%), Twilio Inc (0.7%), Carpenter Technology Corp (0.6%), Nvent Electric Plc (0.6%). It holds 405 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is BKMC's 5-year return?
BKMC returned +8.6% a year over the five years ending Dec 31, 2025. Past performance does not guarantee future results.
Who manages BKMC?
BKMC is offered by BNY Mellon / Dreyfus through BNY Mellon ETF Trust.